| Stage | BE | % of rev | JVA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.2B | 100.00% | $22M | 100.00% | BE ×56.99 |
| Gross profit | $417M | 33.75% | $5M | 25.01% | BE +8.7pp |
| Operating income | $225M | 18.24% | $2M | 10.72% | BE +7.5pp |
| Pre-tax income | $250M | 20.21% | $2M | 10.54% | BE +9.7pp |
| Net income | $249M | 20.15% | $2M | 9.19% | BE +11.0pp |
| Stage | BE | JVA | Gap · A − B |
|---|---|---|---|
| Revenue | $1.2B100.00% | $22M100.00% | BE ×56.99 |
| Gross profit | 33.75%$417M | 25.01%$5M | BE +8.7pp |
| Operating income | 18.24%$225M | 10.72%$2M | BE +7.5pp |
| Pre-tax income | 20.21%$250M | 10.54%$2M | BE +9.7pp |
| Net income |
| 20.15%$249M |
| 9.19%$2M |
| BE +11.0pp |
No disclosed counterparties: JVA.
None